4-Methoxy-1-methylpiperidine-4-carboxylic acid, 97%, 500mg

3H-IMIDAZO[4,5-B]PYRIDINE-2-METHANOL, 5,7-DIMETHYL-, 95.0%, 1g

METHYL 1-FORMYLCYCLOPROPANE-1-CARBOXYLATE, 95.0%, 5g

2-Amino-1-(4-chloro-phenyl)-ethanone; hydrochloride, 95.0%, 5g

Diethyl 2,5-dihydroxyterephthalate, 98.0%, 5g

tert-Butyl (S)-((2-phenyl-5-pivalamido-3-pivaloyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)methyl)carbamate, 98%, 50mg

1,6-Bis(triethoxysilyl)hexane>96.0%(GC)5g

Capilar de punto de fusión, 100 mm, 1,00 mm, 0,80 mm, 1000 Unidad(es)

1-tert-Butoxycarbonyl-3-iodo-1H-pyrazole, 95.0%, 10g

Ciclohexano, mínimo 99,5 %, para síntesis, 5 l, aluminio

2-Fluoro-3-methylbenzonitrile, 98.0%, 5g

1-(1H-1,2,3-triazol-5-yl)methanamine hydrochloride, 95%, 10g

2-Amino-1H-purin-6(7H)-one hydrochloride, 95.0%, 50g